רבלימיד 15 מ"ג

국가: 이스라엘

언어: 히브리어

출처: Ministry of Health

유효 성분:

LENALIDOMIDE 15 MG

제공처:

NEOPHARM SCIENTIFIC LTD

ATC 코드:

L04AX04

약제 형태:

CAPSULES

관리 경로:

PER OS

Manufactured by:

CELGENE EUROPE LTD, UK

치료 그룹:

LENALIDOMIDE

치료 징후:

1. Treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. In combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.

승인 날짜:

2009-04-01